Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STANDARD BIOTOOLS INC.FLDM · Entity 6116 | Director | June 03, 2019 | June 05, 2019 |
| Shapeways Holdings, Inc.SHPW · Entity 90701 | Director | June 08, 2022 | June 10, 2022 |
| Talend S.A.TLND · Entity 136371 | Director | August 09, 2021 | August 11, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STANDARD BIOTOOLS INC.
Report date June 03, 2019 · Filed June 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,087 |
Reported balance
After 2019-06-03 transaction · row 1
1 source rowRow 1 · 2019-06-03 · Grant · Acquired 3,987 · Balance 23,087 F1: Represents Restricted Stock Units that vest in full on the earlier to occur of June 3, 2020 and one day prior to the date of the Issuer's next annual meeting of stockholders. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.41 · Expires 2029-06-03 | Direct | 6,796 |
Reported balance
After 2019-06-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-06-03 · Grant · Acquired 6,796 · Balance 6,796 F2: The Option becomes exercisable in twelve equal monthly installments beginning on July 3, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units that vest in full on the earlier to occur of June 3, 2020 and one day prior to the date of the Issuer's next annual meeting of stockholders.
F2: The Option becomes exercisable in twelve equal monthly installments beginning on July 3, 2019.
Shapeways Holdings, Inc.
Report date June 08, 2022 · Filed June 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,828 |
Reported balance
After 2022-06-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-06-08 · Grant · Acquired 31,250 · Balance 100,828 F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the one-year anniversary of June 8, 2022, subject to the Reporting Person's continuous service with the issuer through such date. F2: The Reporting Person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 31,250 newly awarded RSUs, 56,578 RSUs previously reported in Table II of the Form 4 filed on December 13, 2021 and 13,000 shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the one-year anniversary of June 8, 2022, subject to the Reporting Person's continuous service with the issuer through such date.
F2: The Reporting Person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 31,250 newly awarded RSUs, 56,578 RSUs previously reported in Table II of the Form 4 filed on December 13, 2021 and 13,000 shares of Common Stock.
Talend S.A.
Report date August 09, 2021 · Filed August 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-08-09 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2021-08-09 · Exercise / conversion · Acquired 27,500 · Balance 27,500 Row 2 · 2021-08-09 · Exercise / conversion · Acquired 7,440 · Balance 34,940 Row 3 · 2021-08-09 · Exercise / conversion · Acquired 9,561 · Balance 44,501 Row 4 · 2021-08-09 · Exercise / conversion · Acquired 10,680 · Balance 55,181 Row 5 · 2021-08-09 · Exercise / conversion · Acquired 6,608 · Balance 61,789 Row 6 · 2021-08-09 · Other · Disposed 61,789 · Balance 0 F1: A portion of the proceeds from the reported shares that were disposed of in the tender were sold to cover the aggregate exercise price relating to the exercise of the award. |
| Non-employee Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.13 · Expires 2026-02-04 | Direct | 0 |
Reported balance
After 2021-08-09 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-08-09 · Exercise / conversion · Disposed 27,500 · Balance 0 F2: The exercise price of the non-employee warrant is 11.12 Euros. The U.S. dollar equivalent of the exercise price is $13.13 using the exchange rate as of July 28, 2021 (1.00 = $1.181). F3: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable. |
| Non-employee Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.45 · Expires 2027-05-03 | Direct | 0 |
Reported balance
After 2021-08-09 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-08-09 · Exercise / conversion · Disposed 7,440 · Balance 0 F4: The exercise price of the non-employee warrant is 28.32 Euros. The U.S. dollar equivalent of the exercise price is $33.45 using the exchange rate as of July 28, 2021 (1.00 = $1.181). F3: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable. |
| Non-employee Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.63 · Expires 2028-03-02 | Direct | 0 |
Reported balance
After 2021-08-09 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-08-09 · Exercise / conversion · Disposed 9,561 · Balance 0 F5: The exercise price of the non-employee warrant is 38.64 Euros. The U.S. dollar equivalent of the exercise price is $45.63 using the exchange rate as of July 28, 2021 (1.00 = $1.181). F3: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable. |
| Non-employee Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.29 · Expires 2029-05-16 | Direct | 0 |
Reported balance
After 2021-08-09 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-08-09 · Exercise / conversion · Disposed 10,680 · Balance 0 F6: The exercise price of the non-employee warrant is 42.58 Euros. The U.S. dollar equivalent of the exercise price is $50.29 using the exchange rate as of July 28, 2021 (1.00 = $1.181). F3: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable. |
| Non-employee Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.63 · Expires 2030-08-04 | Direct | 0 |
Reported balance
After 2021-08-09 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2021-08-09 · Exercise / conversion · Disposed 6,608 · Balance 0 F7: The exercise price of the non-employee warrant is 31.02 Euros. The U.S. dollar equivalent of the exercise price is $36.63 using the exchange rate as of July 28, 2021 (1.00 = $1.181). F3: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: A portion of the proceeds from the reported shares that were disposed of in the tender were sold to cover the aggregate exercise price relating to the exercise of the award.
F2: The exercise price of the non-employee warrant is 11.12 Euros. The U.S. dollar equivalent of the exercise price is $13.13 using the exchange rate as of July 28, 2021 (1.00 = $1.181).
F3: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable.
F4: The exercise price of the non-employee warrant is 28.32 Euros. The U.S. dollar equivalent of the exercise price is $33.45 using the exchange rate as of July 28, 2021 (1.00 = $1.181).
F5: The exercise price of the non-employee warrant is 38.64 Euros. The U.S. dollar equivalent of the exercise price is $45.63 using the exchange rate as of July 28, 2021 (1.00 = $1.181).
F6: The exercise price of the non-employee warrant is 42.58 Euros. The U.S. dollar equivalent of the exercise price is $50.29 using the exchange rate as of July 28, 2021 (1.00 = $1.181).
F7: The exercise price of the non-employee warrant is 31.02 Euros. The U.S. dollar equivalent of the exercise price is $36.63 using the exchange rate as of July 28, 2021 (1.00 = $1.181).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2022 Filed Jun 10, 2022 08:28 UTC | Shapeways Holdings, Inc. SHPW · Entity 90701 | GrantCommon Stock | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-016761 · wf-form4_165486408268452.xml · nonDerivative · entry 1 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,828 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the one-year anniversary of June 8, 2022, subject to the Reporting Person's continuous service with the issuer through such date. F2 · balance_after: The Reporting Person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 31,250 newly awarded RSUs, 56,578 RSUs previously reported in Table II of the Form 4 filed on December 13, 2021 and 13,000 shares of Common Stock. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 20:11 UTC | Shapeways Holdings, Inc. SHPW · Entity 90701 | GrantRestricted Stock Unit · Derivative | 56,578 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047962 · doc4.xml · derivative · entry 2 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,578 Underlying: Common Stock · 56,578 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied in three annual installments on each anniversary of October 1, 2021, subject to the Reporting Person's continuous service with the issuer through each such anniversary. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied in three annual installments on each anniversary of October 1, 2021, subject to the Reporting Person's continuous service with the issuer through each such anniversary. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied in three annual installments on each anniversary of October 1, 2021, subject to the Reporting Person's continuous service with the issuer through each such anniversary. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 16:38 UTC | Shapeways Holdings, Inc. SHPW · Entity 90701 | OtherCommon Stock | 13,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-045404 · doc4.xml · nonDerivative · entry 1 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 F1 · price: On November 17, 2021, Galileo Founders Holdings, L.P. dissolved and effected a pro rata distribution-in-kind to its members, comprising 2,760,000 shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") and 4,062,000 private warrants (the "Distribution"). F2 · balance_after: Represents 13,000 shares of Common Stock received by the Reporting Person in the Distribution. The acquisition of such shares by the Reporting Person is exempt from Section 16 of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16a-9 thereunder. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 6,608 | $1.78 Strike: $36.63 | $11,784.05 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · derivative · entry 11 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,608 shares Expires 2030-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The exercise price of the non-employee warrant is 31.02 Euros. The U.S. dollar equivalent of the exercise price is $36.63 using the exchange rate as of July 28, 2021 (1.00 = $1.181). F3 · derivative.exercise_date: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 10,680 | $2.55 Strike: $50.29 | $27,244.68 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · derivative · entry 10 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,680 shares Expires 2029-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The exercise price of the non-employee warrant is 42.58 Euros. The U.S. dollar equivalent of the exercise price is $50.29 using the exchange rate as of July 28, 2021 (1.00 = $1.181). F3 · derivative.exercise_date: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 9,561 | $6.60 Strike: $45.63 | $63,119.81 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · derivative · entry 9 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,561 shares Expires 2028-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The exercise price of the non-employee warrant is 38.64 Euros. The U.S. dollar equivalent of the exercise price is $45.63 using the exchange rate as of July 28, 2021 (1.00 = $1.181). F3 · derivative.exercise_date: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 7,440 | $4.91 Strike: $33.45 | $36,552.72 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · derivative · entry 8 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,440 shares Expires 2027-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The exercise price of the non-employee warrant is 28.32 Euros. The U.S. dollar equivalent of the exercise price is $33.45 using the exchange rate as of July 28, 2021 (1.00 = $1.181). F3 · derivative.exercise_date: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 27,500 | $0.66 Strike: $13.13 | $18,062.00 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · derivative · entry 7 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 27,500 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 11.12 Euros. The U.S. dollar equivalent of the exercise price is $13.13 using the exchange rate as of July 28, 2021 (1.00 = $1.181). F3 · derivative.exercise_date: The Ordinary Shares underlying the warrant are fully vested and immediately exercisable. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | OtherOrdinary Shares | 61,789 | $66.00 | $4,078,074.00 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · nonDerivative · entry 6 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: A portion of the proceeds from the reported shares that were disposed of in the tender were sold to cover the aggregate exercise price relating to the exercise of the award. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | Exercise / conversionOrdinary Shares | 6,608 | $36.63 | $242,051.04 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · nonDerivative · entry 5 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | Exercise / conversionOrdinary Shares | 10,680 | $50.29 | $537,097.20 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · nonDerivative · entry 4 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | Exercise / conversionOrdinary Shares | 9,561 | $45.63 | $436,268.43 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · nonDerivative · entry 3 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | Exercise / conversionOrdinary Shares | 7,440 | $33.45 | $248,868.00 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · nonDerivative · entry 2 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:49 UTC | Talend S.A. TLND · Entity 136371 | Exercise / conversionOrdinary Shares | 27,500 | $13.13 | $361,075.00 |
DisclosureSEC source: 0001209191-21-050880 · doc4.xml · nonDerivative · entry 1 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 17:44 UTC | Talend S.A. TLND · Entity 136371 | GrantNon-employee Warrant (right to buy) · Derivative | 6,608 | $1.78 Strike: $36.50 | $11,762.24 |
DisclosureSEC source: 0001209191-20-045541 · doc4.xml · derivative · entry 1 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,608 Underlying: Ordinary Shares · 6,608 shares Expires 2030-08-04 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 31.02 Euros. The U.S. dollar equivalent of the exercise price is $36.50 using the European Central Bank rate as of August 4, 2020 (1.00 = $1.1765). F4 · price: The subscription price of the non-employee warrant is 1.51 Euros per warrant. The U.S. dollar equivalent of the subscription price is $1.78 using the European Central Bank rate as of August 4, 2020 (1.00 = $1.1765). F2 · derivative.exercise_date: The Ordinary Shares underlying the warrant vest in four equal quarterly installments beginning on November 4, 2020. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 17:39 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 6,796 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0001162194-19-000050 · wf-form4_155975634622253.xml · derivative · entry 2 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,796 Underlying: Common Stock · 6,796 shares Expires 2029-06-03 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly installments beginning on July 3, 2019. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 17:39 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 3,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000050 · wf-form4_155975634622253.xml · nonDerivative · entry 1 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,087 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 3, 2020 and one day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:22 UTC | Talend S.A. TLND · Entity 136371 | GrantNon-employee Warrant (right to buy) · Derivative | 11,987 | $0.00 Strike: $47.62 | $0.00 |
DisclosureSEC source: 0001209191-19-031594 · doc4.xml · derivative · entry 1 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,987 Underlying: Ordinary Shares · 11,987 shares Expires 2029-05-16 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 42.58 Euros. The U.S. dollar equivalent of the exercise price is $47.62 using the European Central Bank rate as of December 31, 2018 (1.00 = $1.1183). F2 · derivative.exercise_date: The Ordinary Shares underlying the warrant vest in four equal quarterly installments beginning on August 16, 2019. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| May 16, 2019 Filed Feb 26, 2020 18:56 UTC Amendment | Talend S.A. TLND · Entity 136371 | GrantNon-employee Warrant (right to buy) · Derivative | 10,680 | $2.42 Strike: $47.62 | $25,845.60 |
DisclosureSEC source: 0001209191-20-013211 · doc4a.xml · derivative · entry 1 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,680 Underlying: Ordinary Shares · 10,680 shares Expires 2029-05-16 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 42.58 Euros. The U.S. dollar equivalent of the exercise price is $47.62 using the European Central Bank rate as of December 31, 2018 (1.00 = $1.1183). F4 · price: The subscription price of the non-employee warrant is 2.16 Euros per warrant. The U.S. dollar equivalent of the subscription price is $2.42 using the European Central Bank rate as of December 31, 2018 (1.00 = $1.1183). F2 · derivative.exercise_date: The Ordinary Shares underlying the warrant vest in four equal quarterly installments beginning on August 16, 2019. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| May 31, 2018 Filed Jun 2, 2018 00:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 10,600 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0001162194-18-000078 · wf-form4_152790101456184.xml · derivative · entry 6 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,600 Underlying: Common Stock · 10,600 shares Expires 2028-05-31 F5 · derivative.exercise_date: 1/12th of the shares subject to the Option will vest monthly over twelve months, subject to continued service as a director, such that the Option will be fully vested on May 31, 2019. Read SEC document |
| May 31, 2018 Filed Jun 2, 2018 00:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 6,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000078 · wf-form4_152790101456184.xml · nonDerivative · entry 3 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,100 F1 · security: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · shares: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) May 31, 2019, in each case subject to recipient's continued service as a director through the applicable vest date. Read SEC document |
| May 30, 2018 Filed Jun 2, 2018 00:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000078 · wf-form4_152790101456184.xml · derivative · entry 5 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4 · derivative.exercise_date: On September 13, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. F4 · derivative.expiration_date: On September 13, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. Read SEC document |
| May 30, 2018 Filed Jun 2, 2018 00:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000078 · wf-form4_152790101456184.xml · derivative · entry 4 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On August 1, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. F3 · derivative.expiration_date: On August 1, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. Read SEC document |
| May 30, 2018 Filed Jun 2, 2018 00:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000078 · wf-form4_152790101456184.xml · nonDerivative · entry 2 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2018 Filed Jun 2, 2018 00:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000078 · wf-form4_152790101456184.xml · nonDerivative · entry 1 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 01:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $5.44 | $0.00 |
DisclosureSEC source: 0001162194-17-000130 · wf-form4_150543757621194.xml · derivative · entry 2 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2027-08-01 F3 · derivative.exercise_date: 1/12th of the total number of shares subject to the Option will vest each month after the Vesting Commencement Date, on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the Option will be fully vested one year following the Vesting Commencement Date, subject to recipient continuing to serve as a director of the Company through each such vesting date. "Vesting Commencement Date" shall mean August 1, 2017. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 01:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000130 · wf-form4_150543757621194.xml · derivative · entry 1 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) August 1, 2018, in each case subject to recipient's continued service as a director through the applicable vest date. F2 · derivative.expiration_date: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) August 1, 2018, in each case subject to recipient's continued service as a director through the applicable vest date. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 00:36 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0001162194-17-000087 · wf-form4_150172055168210.xml · derivative · entry 4 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2027-08-01 F3 · derivative.exercise_date: 1/12th of the shares subject to the Option will vest monthly, subject to continued service as a director, such that the Option will be fully vested on August 1, 2018. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 00:36 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000087 · wf-form4_150172055168210.xml · derivative · entry 3 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 1, 2018, subject to continued service as a director through the vesting date. F2 · derivative.expiration_date: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 1, 2018, subject to continued service as a director through the vesting date. Read SEC document |
| July 31, 2017 Filed Aug 3, 2017 00:36 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000087 · wf-form4_150172055168210.xml · derivative · entry 2 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2017-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Read SEC document |
| July 31, 2017 Filed Aug 3, 2017 00:36 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000087 · wf-form4_150172055168210.xml · nonDerivative · entry 1 JONES PATRICK S · CIK 0001232558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.